Intralytix (United States)
Intralytix, Inc. is a privately owned biotech venture incorporated in the State of Maryland on July 28, 1998. Intralytix specializes in bacteriophage based products used to control bacterial pathogens in environmental, agricultural, food processing, and medical settings. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Intralytix (United States), United States, covering academic research published from 2003 to 2024. Read More.
Open Access Percentage
76%
Total
Publications
75
Total Open
Publications
57
Total
Citations
4.4K
Open Access
Percentage
76%
Total
Publications
75
Total Open
Publications
57
Total
Citations
4.4K
Breakdown
Publisher Open
20%
Both
44%
Other Platform Open
12%
Closed
24%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 37%
18
Hybrid 44%
21
No Guarantees 19%
9
Other Platform Open
Domain 86%
36
Institution 19%
8
Public 12%
5
Other Internet 10%
4
Preprint 5%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 35 |
Europe PMC | Domain | 25 |
Semantic Scholar | Public | 4 |
DOI | Other Internet | 4 |
Vrije Universiteit Amsterdam - VU Research Portal | Institution | 3 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes | Institution | 2 |
bioRxiv | Preprint | 2 |
whiterose.ac.uk OAI-PMH Repository | Institution | 1 |
University of Copenhagen - Research at the University of Copenhagen | Institution | 1 |